Forgot your password?

Forgot your username?

Epion Health Receives $4.5M Series A Funding from Deerfield Management

Posted on 01 Oct 2014

OneMedMarket is pleased to report that its member company Epion Health announced the closing of a $4.5M Series A financing round with Deerfield Management Company, a leading national venture fund.

“We are delighted to see Epion get funded. For the pas

8th Annual OneMedForum San Francisco: New Venue & Partnership Announced

Posted on 01 Oct 2014

Forum makes moves to an expanded venue for the launch of OneMedMarket.

OneMedForum announced that its 8th annual conference will move to the San Francisco Marriott Marquis, January 12-14,

NanoViricides Opens New Facility in Shelton, CT for Production of Drug Candidates

Posted on 01 Oct 2014

NanoViricides, Inc. (NYSE MKT:

The First OneMedMarket Conference

Posted on 11 Jun 2014

On May 21, 2014, the first OneMedMarket conference was held in New York City. Accredited investors turned out from all over for presentations from eleven CEOs of curated, candidate healthcare technology companies. The presentations were webcast to over a hun

Editor’s Note

Posted on 03 Apr 2014

Dear Subscriber,

In the coming weeks, the sentinel will be featuring articles on emerging private growth companies in the health sector that will be presenting at the first OneMedMarketplace in New York City on May 21st. These companies are game-chang

The Whirl of Wound Care

Posted on 29 Mar 2014
However irksome it may be to think about open or healing wounds, the medical advances and market potential in this niche space is quite appealing for investors. Globally, there are 50 million reported cases of patients suffering from some type of wound that may be difficult to close o

SpectraScience: Innovations in Cancer Detection

Posted on 04 Jan 2014
SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.

DesignMedix: Overcoming Drug Resistance

Posted on 02 Jan 2014
DesignMedix places great emphasis on tackling problems of drug resistant diseases, such as malaria, bacteria, and cancer.

BioLife Solutions: Powering the Preservation Sciences

Posted on 31 Dec 2013
BioLife Solutions has a strong interest in target markets: regenerative medicine, biobanking, and drug discovery.